90
Participants
Start Date
August 31, 1998
Primary Completion Date
January 31, 2001
Study Completion Date
January 31, 2001
anti-thymocyte globulin
busulfan
cyclophosphamide
cyclosporine
melphalan
methylprednisolone
umbilical cord blood transplantation
radiation therapy
New York Blood Center, New York
Duke Comprehensive Cancer Center, Durham
University of South Carolina School of Medicine, Columbia
Division of Pediatric Surgery, Jacksonville
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Rush-Presbyterian-St. Luke's Medical Center, Chicago
University of Chicago Cancer Research Center, Chicago
Cardinal Glennon Children's Hospital, St Louis
Children's Hospital of New Orleans, New Orleans
University of Florida Health Science Center, Gainesville
Hackensack University Medical Center, Hackensack
Roswell Park Cancer Institute, Buffalo
Lineberger Comprehensive Cancer Center, UNC, Chapel Hill
St. Christopher's Hospital for Children, Philadelphia
Medical University of South Carolina, Charleston
National Cancer Institute (NCI)
NIH
Roswell Park Cancer Institute
OTHER